Acasti Pharma reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2022.


Gross Profit On Sales Change Date
Acasti Pharma USD 0 0 Mar/2022
Addus HomeCare USD 113.88M 6.2M Jun/2025
Amarin USD 25.13M 1.78M Mar/2025
Cassava Sciences USD -5120000 22.82M Jun/2025
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Option Care Health USD 269.04M 5.99M Jun/2025
Organigram Holdings CAD 26.15M 25.1M Jun/2025
Tilray USD 61.22M 1.51M Nov/2024